FDA allows marketing of a new device, ClearMate, intended to be used with patients suffering from carbon monoxide poisoning. This is the first carbon monoxide poisoning device authorized for marketing by the FDA for use in an emergency room setting.
from Food and Drug Administration--Press Releases https://ift.tt/2T2eDm5
via IFTTT
No comments:
Post a Comment